Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
News Release
COVID-19 Update
With the heightened concern about a potential 2019 Novel Coronavirus (COVID-19) outbreak, Mitchell is working diligently to ensure the health and s
Workers' Comp
Article
Topical Medications in Workers' Compensation and Auto Casualty
This article is part of our ongoing Quarterly Drug Update series.
Mitchell
News Release
Mitchell Pharmacy Solutions Responds to COVID-19 National Emergency
The country is facing an unprecedented emergency related to the COVID-19 virus and it is disrupting many facets of our daily lives.
Workers' Comp
Blog
Post-traumatic Stress Disorder and Workers’ Comp
PTSD typically starts with exposure to a critical incident.
Mitchell
Article
The Realization of Claims Virtualization
Five years ago, if someone mentioned “claims virtualization,” it most likely referred to an insurance carrier’s mobile application, or possibly jus
Mitchell
Article
The Impact of Calibration Needs on Collision Repair
With the increasing ubiquity of Advanced Driver Assi